DUSP1 and pachyonychia congenita: Whereas DUSP1 levels are high in benign prostatic hyperplasia (BPH) and hormone-sensitive prostatic adenocarcinoma (HS-PC), the expression of this phosphatase is almost absent in hormone-refractory prostatic adenocarcinoma (HR-PC) [17,18].